OnKure Therapeutics, Inc. (OKUR)
 NASDAQ: OKUR · Real-Time Price · USD
 3.360
 +0.010 (0.30%)
  At close: Oct 31, 2025, 4:00 PM EDT
3.390
 +0.030 (0.89%)
  After-hours: Oct 31, 2025, 4:10 PM EDT
OnKure Therapeutics Employees
OnKure Therapeutics had 46 employees as of December 31, 2024.
Employees 
 46
Change 
 n/a
Growth 
 n/a
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,311,152
Market Cap 
45.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 46 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
OKUR News
- 2 months ago - OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update - GlobeNewsWire
- 6 months ago - OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 8 months ago - OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 8 months ago - OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences - GlobeNewsWire
- 11 months ago - OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219 - GlobeNewsWire
- 1 year ago - OnKure Announces New Date for Upcoming Investor Call - GlobeNewsWire
- 1 year ago - OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 1 year ago - OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond - Seeking Alpha